Author
N. Burgess-Brown
University of OxfordORCID 0000-0003-0463-445XUnclaimed ORCID profile · follow to get notified of new preprints
Additional preprints under this name without ORCID
Biology Disciplines
Click to filter author papersSignature Assays, Organisms & Methods
Click to filter · or open tagActivity by Year
2019-2026 · peak 3/yrCo-Author Collaboration Network
10 top collaborators · 11 mutual co-author links5 papers
Recent·Most cited
- BiochemistryiSciencePeer-reviewed
Engineered HMGB1 construct with tandem Box B domains promotes tissue regeneration without potential for deleterious inflammation or thrombosis
Alvaro Viñals Guitart, Carl Lee, Ana Isabel Espirito Santo…·Jagdeep Nanchahal
1 citationtop 5% - Pharmacology & ToxicologyProceedings of the National Academy of SciencesPeer-reviewed
High-throughput protein target mapping enables accelerated bioactivity discovery for ToxCast and PFAS compounds
Diwen Yang, Xiaoyun Wang, Jiabao Liu…·Hui Peng
The paper uses high-throughput affinity-selection mass spectrometry to identify protein targets of ToxCast and PFAS compounds, discovering novel interactions and revealing distinct binding patterns of legacy and replacement PFAS.
4 citationstop 3% - Molecular BiologyStructurePeer-reviewed
Selection and structural characterisation of anti-TREM2 scFvs that reduce levels of shed ectodomain
Aleksandra Szykowska, Yu Chen, Thomas B. Smith…·Alex N. Bullock
The paper identifies and characterizes anti-TREM2 scFv antibodies that inhibit soluble TREM2 production.
19 citations - Molecular BiologybioRxivPreprint
A unique lower X-gate in TASK channels traps inhibitors within the vestibule
Karin E. J. Rödström, Aytuğ K. Kiper, Wei Zhang…·Elisabeth P. Carpenter
This paper reveals the structure of TASK-1 channels, identifying a unique lower X-gate that traps inhibitors in the vestibule, explaining their slow washout and pharmacological properties.